文献速递胃肠外科急腹症与外科感染

腹腔镜食管裂孔疝修补术是否使用补片?一项系统文献综述及新型时间组织比例Meta分析

Cruroplasty with or without mesh? A systematic literature review with a novel time-organized proportion meta-analysis.
PubMed 文献 · Surg Endosc · 2024-02-13

该系统综述纳入1993年1月至2022年9月间34项研究(含6项随机临床试验、25项回顾性研究、3项前瞻性队列研究),共2170例接受腹腔镜食管裂孔疝修补术且客观随访≥6个月的患者。结果显示,可吸收补片组客观复发率20.6%与单纯缝合修补组20.8%相近,不可吸收补片组为13.7%,部分可吸收补片组为0%。配对Meta分析显示补片总体使用并未优于单纯缝合修补,长期(≥48个月)复发率使用或不使用任何类型补片相似。

要点

  • 可吸收补片不降低食管裂孔疝客观复发率,与单纯缝合修补相近。
  • 不可吸收补片中期可降低客观复发率,但长期(≥48个月)复发率与不用补片相似。
  • 补片总体使用在预防长期食管裂孔疝复发方面未优于单纯缝合修补。

核心结论

  • 可吸收补片的使用与单纯缝合修补相比,似乎并未降低食管裂孔疝的客观复发率。
  • 尽管数据支持不可吸收补片在中期降低客观复发率,但长期(≥48个月)复发率使用或不使用任何类型补片相似。

研究设计与样本

  • 系统文献综述,包含配对Meta分析和时间组织比例Meta分析。
  • 检索MEDLINE、EMBASE和Taylor & Francis数据库,纳入1993年1月至2022年9月发表的文章。
  • 共纳入34项研究,包括6项随机临床试验、25项回顾性研究和3项前瞻性队列研究。
  • 共2170例受试者接受腹腔镜食管裂孔疝修补术,并完成术后≥6个月的客观随访。

主要发现

  • 单纯缝合修补组客观复发率为20.8%(99/477),平均随访25.8±16.4个月。
  • 可吸收补片组客观复发率为20.6%(244/1187),平均随访28.1±13.8个月。
  • 不可吸收补片组客观复发率为13.7%(65/475),平均随访30.8±15.3个月。
  • 部分可吸收补片组客观复发率为0%(0/31),平均随访32.5±13.5个月。
  • 配对Meta分析显示,补片总体使用在预防长期食管裂孔疝复发方面未优于单纯缝合修补。

关键数值与推荐

  • 纳入标准:文献需记录客观随访≥6个月。
  • 主要结局:经钡餐食管造影或上消化道内镜证实的食管裂孔疝复发率。
  • 比较组:单纯缝合修补、可吸收补片、不可吸收补片或部分可吸收补片。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improved outcomes with the use of non-absorbable mesh (NAM) for inguinal hernia repairs led to its rapid adoption for hiatal hernia (HH) repairs; however, feared complications occurred, and the trend shifted toward using absorbable mesh (AM). We aimed to analyze the literature assessing objective HH recurrence rates after primary laparoscopic cruroplasty with or without the use of different mesh types. METHODS: A systematic literature review with both pairwise and time-organized proportion meta-analyses of articles published between January 1993 and September 2022 was performed using the MEDLINE, EMBASE, and Taylor & Francis databases to identify relevant studies comparing groups undergoing cruroplasty with suture repair (SR) alone, AM, NAM, or partially absorbable mesh (PAM). Studies documenting an objective follow-up ≥ 6 months were included. The primary outcome was the HH recurrence rate confirmed by barium esophagram or upper GI endoscopy. RESULTS: A total of 34 studies met the inclusion criteria, including 6 randomized clinical trials, 25 retrospectives studies, and 3 prospective cohort studies. A total of 2170 subjects underwent laparoscopic HH repair and completed an objective follow-up ≥ 6 months after surgery; the objective recurrence rate was 20.8% (99/477) at a mean follow-up of 25.8 ± 16.4 months for the SR group, 20.6% (244/1187) at 28.1 ± 13.8 months for the AM group, 13.7% (65/475) at 30.8 ± 15.3 months for the NAM group, and 0% (0/31) at 32.5 ± 13.5 months for the PAM group. However, the pairwise meta-analysis revealed that overall mesh use was not superior to SR in preventing long-term HH recurrence. CONCLUSION: The use of AM does not appear to reduce HH recurrence compared to SR alone. Although the data favors NAM to decrease objective HH recurrence in the mid-term, the long-term (≥ 48 months) recurrence rate was similar with or without any type of mesh.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Latorre-Rodríguez AR, Rajan A, Mittal SK, et al. Cruroplasty with or without mesh? A systematic literature review with a novel time-organized proportion meta-analysis. Surg Endosc. 2024. PMID: 38351425. doi:10.1007/s00464-024-10683-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。